title: Neutralizing the anticoagulant activity of ultra-low-molecular-weight heparins using N-acetylglucosamine 6-sulfatase.
abstract: Heparin has been the most commonly used anticoagulant drug for nearly a century. The drug heparin is generally categorized into three forms according to its molecular weight: unfractionated (UF, average molecular weight 13 000), low molecular weight (average molecular weight 5000) and ultra-low-molecular-weight heparin (ULMWH, average molecular weight 2000). An overdose of heparin may lead to very dangerous bleeding in patients. Protamine sulfate may be administered as an antidote to reverse heparin's anticoagulant effect. However, there is no effective antidote for ULMWH. In the current study, we examine the use of human N-acetylglucosamine 6-sulfatase (NG6S), expressed in Chinese hamster ovary cells, as a reversal agent for ULMWH. NG6S removes a single 6-O-sulfo group at the non-reducing end of the ULMWH Arixtra(®) (fondaparinux), effectively removing its ability to bind to antithrombin and preventing its inhibition of coagulation factor Xa. These results pave the way to developing human NG6S as an antidote for neutralizing the anticoagulant activity of ULMWHs.
authors: College of Biotechnology and Food Engineering, Hefei University of Technology, Anhui, China.
authors: Xianxuan
authors: X
authors: Zhou
authors: Lingyun
authors: L
authors: Li
authors: Robert J
authors: RJ
authors: Linhardt
authors: Jian
authors: J
authors: Liu
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000737:chemistry; D000931:Antidotes / Q000737:chemistry; D001665:Binding Sites; D015153:Blotting, Western; D016466:CHO Cells; D002851:Chromatography, High Pressure Liquid; D006224:Cricetinae; D004789:Enzyme Activation; D000077425:Fondaparinux; D006494:Heparin Antagonists / Q000737:chemistry*; D006495:Heparin, Low-Molecular-Weight / Q000037:antagonists & inhibitors* / Q000737:chemistry; D006801:Humans; D008970:Molecular Weight; D010957:Plasmids / Q000737:chemistry; D011134:Polysaccharides / Q000737:chemistry; D013429:Sulfatases / Q000737:chemistry* / Q000235:genetics / Q000494:pharmacology; D013997:Time Factors; D014162:Transfection
chemical_list: D000925:Anticoagulants; D000931:Antidotes; D006494:Heparin Antagonists; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D013429:Sulfatases; C018719:N-acetylglucosamine-6-sulfatase; D000077425:Fondaparinux
references: Anal Bioanal Chem. 2011 Jan;399(2):527-39
references: 20814668
references: Annu Rev Biochem. 1999;68:729-77
references: 10872465
references: Science. 2011 Oct 28;334(6055):498-501
references: 22034431
references: Curr Drug Discov Technol. 2012 Jun 1;9(2):143-9
references: 22023256
references: Structure. 1997 Feb 15;5(2):277-89
references: 9032078
references: Annu Rev Cell Biol. 1992;8:365-93
references: 1335744
references: J Biol Chem. 2001 Aug 3;276(31):28806-13
references: 11375390
references: Nat Prod Rep. 2002 Jun;19(3):312-31
references: 12137280
references: Anal Chem. 2008 Dec 1;80(23):9204-12
references: 19551986
references: Nat Chem Biol. 2006 Apr;2(4):195-6
references: 16532012
references: Biochemistry. 1985 Nov 5;24(23):6723-9
references: 4084555
references: Trends Cell Biol. 2001 Feb;11(2):75-82
references: 11166215
references: Thromb Res. 2000 Oct 15;100(2):V113-20
references: 11053624
references: J Biol Chem. 2010 Oct 29;285(44):34240-9
references: 20729556
references: Nat Rev Drug Discov. 2009 May;8(5):353-4
references: 19390569
references: J Chromatogr A. 1997 Mar 28;765(2):169-79
references: 9129307
references: Biochem J. 1992 Dec 1;288 ( Pt 2):539-44
references: 1463457
references: Biochem J. 1997 Oct 1;327 ( Pt 1):89-94
references: 9355739
references: J Biotechnol. 2008 Feb 1;133(3):294-300
references: 18077046
references: J Biol Chem. 1973 Sep 25;248(18):6490-505
references: 4738234
references: Curr Opin Chem Biol. 2000 Dec;4(6):626-31
references: 11102866
references: Anal Chem. 2012 Jul 3;84(13):5475-8
references: 22715938
references: Biochem J. 2005 May 1;387(Pt 3):841-7
references: 15595925
references: J Med Chem. 2003 Jun 19;46(13):2551-64
references: 12801218
references: Nat Prod Rep. 2009 Mar;26(3):313-21
references: 19240943
references: Appl Microbiol Biotechnol. 2012 Jan;93(1):1-16
references: 22048616
references: Glycobiology. 2001 Jun;11(6):505-13
references: 11445555
references: J Clin Invest. 2001 Jul;108(2):169-73
references: 11457867
references: Biochim Biophys Acta. 2004 Mar 17;1671(1-3):34-43
references: 15026143
references: Nat Chem Biol. 2012 Jan 08;8(2):197-204
references: 22231271
references: Nephrol Dial Transplant. 2005 Feb;20(2):444-6
references: 15673695
references: J Pharm Pract. 2010 Jun;23(3):235-8
references: 21507819
references: Angew Chem Int Ed Engl. 2004 Jun 14;43(24):3118-33
references: 15199558
references: Cell. 2005 May 20;121(4):541-552
references: 15907468